Status | Study |
Completed |
Study Name: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) Condition: B-cell Chronic Lymphocytic Leukemia Hematopoietic/Lymphoid Cancer Date: 2010-09-10 Interventions: Drug: carfilzomib Given IV inf |
Completed |
Study Name: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) Condition: T-cell-prolymphocytic Leukemia Date: 2010-08-20 Interventions: Drug: Fludarabine, Mitoxantrone, Cyclophosphamide and Alemtuzumab |
Withdrawn |
Study Name: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia Condition: Leukemia Acute Lymphocytic Leukemia Date: 2010-07-12 Interventions: Drug: Velcade IV Other Name: Bortezomib |
Terminated |
Study Name: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia Condition: B-cell Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Date: 2010-05-18 Interventions: Drug: alvespimycin hydrochloride |
Completed |
Study Name: A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) Condition: Solid Tumors Chronic Lymphocytic Leukemia T-cell- Date: 2008-09-05 Interventions: Drug: MK-4827 MK-4827 in 10 mg and 100 mg capsules given daily in a 21 day dosing cycle (dose escalation |
Terminated |
Study Name: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia Condition: Leukemia, Lymphoma, Chronic Lymphocytic Leukemia, Prolymphocytic Date: 2007-12-21 Interventions: Drug: CAT-8015 5 mcg/kg Partic |
Completed |
Study Name: Oxaliplatin, Fludarabine, Cytarabine, and Rituximab in Patients With Richter's Transformation and Leukemias Condition: Richter's Transformation Leukemia Date: 2007-05-11 Interventions: Drug: Oxaliplatin Oxaliplatin |
Completed |
Study Name: Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL) Condition: Leukemia, Lymphocytic, Chronic Date: 2007-04-20 Interventions: Drug: alvocidib 1st dose: 30 mg/m2 as a 30-minute intraven |
Terminated |
Study Name: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia Condition: Prolymphocytic Leukemia Date: 2006-01-24 Interventions: Biological: rituximab Drug: cyclophosphami |
Completed |
Study Name: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condition: Prolymphocytic Leukemia Date: 2006-01-16 Interventions: Biological: alemtuzumab Drug: cyclophospha |